[
  {
    "category": "company",
    "datetime": 1746784111,
    "headline": "TransMedics: Exceptional Q1 Undermines The Short Narrative",
    "id": 134339517,
    "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/688000635/image_688000635.jpg?io=getty-c-w1536",
    "related": "TMDX",
    "source": "SeekingAlpha",
    "summary": "TransMedics posted strong Q1 results, easing fears of prior weakness and short pressure, while expanding logistics and devices. Learn why TMDX stock is a buy.",
    "url": "https://finnhub.io/api/news?id=02d6bcb5632e1cf0e900a9a77c980005f6268915f7c94e030a07d825d59ffac0"
  },
  {
    "category": "company",
    "datetime": 1746776503,
    "headline": "TransMedics Group Inc (TMDX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...",
    "id": 134337448,
    "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
    "related": "TMDX",
    "source": "Yahoo",
    "summary": "TransMedics Group Inc (TMDX) reports impressive revenue growth and improved margins, while addressing potential market and regulatory challenges.",
    "url": "https://finnhub.io/api/news?id=62d8a0161c3235c330ba7f895698f2f0b0918b1c63a0e2a7785f5f4c28864679"
  },
  {
    "category": "company",
    "datetime": 1746745205,
    "headline": "Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics",
    "id": 134337449,
    "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
    "related": "TMDX",
    "source": "Yahoo",
    "summary": "The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=1d44634ff01618bb456ac2e69cfeb9d2c4beac07ccb3a4ec6c9b9ed40ae0e085"
  },
  {
    "category": "company",
    "datetime": 1746744024,
    "headline": "TransMedics Group, Inc. (TMDX) Q1 2025 Earnings Call Transcript",
    "id": 134332610,
    "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
    "related": "TMDX",
    "source": "SeekingAlpha",
    "summary": "TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsLaine Morgan - Gilmartin Group, Investor...",
    "url": "https://finnhub.io/api/news?id=bc82f52086f9d88a8a94d4fb2d7757562b018f66eab63777d9dbd8bcf5a49058"
  },
  {
    "category": "company",
    "datetime": 1746741008,
    "headline": "TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates",
    "id": 134337450,
    "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
    "related": "TMDX",
    "source": "Yahoo",
    "summary": "TransMedics (TMDX) delivered earnings and revenue surprises of 141.38% and 16.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=35ce43b3b7fcaa9e926c088bcf04154a818e43288660243c487509a4ed0bd8ab"
  },
  {
    "category": "company",
    "datetime": 1746737348,
    "headline": "TransMedics: Q1 Earnings Snapshot",
    "id": 134337451,
    "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
    "related": "TMDX",
    "source": "Yahoo",
    "summary": "TMDX) on Thursday reported first-quarter profit of $25.7 million. On a per-share basis, the Andover, Massachusetts-based company said it had profit of 70 cents. The results topped Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=0df754cd5817d2846f8a7ec0792586b08eda67f1b7ad071fc0d36842147f8d2b"
  },
  {
    "category": "company",
    "datetime": 1746734700,
    "headline": "TransMedics Reports First Quarter 2025 Financial Results",
    "id": 134337452,
    "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
    "related": "TMDX",
    "source": "Yahoo",
    "summary": "TransMedics Group, Inc. (\"TransMedics\") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2025.",
    "url": "https://finnhub.io/api/news?id=66c850af55771ab49a69d7f9efd70563ceee5a417d78dec602985378731ce184"
  },
  {
    "category": "company",
    "datetime": 1746730378,
    "headline": "TransMedics Group, Inc. 2025 Q1 - Results - Earnings Call Presentation",
    "id": 134331661,
    "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
    "related": "TMDX",
    "source": "SeekingAlpha",
    "summary": "The following slide deck was published by TransMedics Group, Inc.",
    "url": "https://finnhub.io/api/news?id=42fedb70859502766c0c3263a186349acab8dd3c4836028b6ef88601d604cece"
  },
  {
    "category": "company",
    "datetime": 1746719352,
    "headline": "Scorpion Capital Says Remain Short Transmedics",
    "id": 134330341,
    "image": "",
    "related": "TMDX",
    "source": "Finnhub",
    "summary": "Transmedics Group Inc: * SCORPION CAPITAL - WE REMAIN SHORT TRANSMEDICSSource text: https://tinyurl.com/33t4tmm5Further company coverage: ...",
    "url": "https://finnhub.io/api/news?id=9435d8c76295e9ef632fe1f61f952247711c1cbf5d6954d3c99cfd686b074e19"
  },
  {
    "category": "company",
    "datetime": 1746469727,
    "headline": "Investing in TransMedics Group (NASDAQ:TMDX) five years ago would have delivered you a 433% gain",
    "id": 134268108,
    "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
    "related": "TMDX",
    "source": "Yahoo",
    "summary": "Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...",
    "url": "https://finnhub.io/api/news?id=67dd48c1a854d1ee1d683caf9d005eb569aee14b6047571e7997386186d57115"
  },
  {
    "category": "company",
    "datetime": 1746450946,
    "headline": "Insights Into TransMedics (TMDX) Q1: Wall Street Projections for Key Metrics",
    "id": 134248536,
    "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
    "related": "TMDX",
    "source": "Yahoo",
    "summary": "Get a deeper insight into the potential performance of TransMedics (TMDX) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "url": "https://finnhub.io/api/news?id=f39e986469ad9f685fbedb1b270ebef07bb8385560440735a01271011dc1aa42"
  }
]
